Study: Newer hypertension drugs cut risk of diabetes

09/6/2006 | Reuters

A new analysis of a major European study indicates patients given a mix of newer blood pressure drugs are one-third less likely to develop diabetes than those on older medicines. The study compared a regimen of a beta blocker and a diuretic with a combination of Pfizer's more recent Norvasc, a calcium channel blocker, and Coversyl, an ACE inhibitor developed by France's Servier and marketed in the U.S. Aceon.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Litigation
Center for Science in the Public Interest
Washington, DC
Health Plan CEO - Oregon
Trillium Community Health Plan
Eugene, OR
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Associate General Counsel
Patient-Centered Outcomes Research Institute
Washington, D.C , DC